Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 313

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 313
---
ed 
 Common Warrant      |          |     | Total |           |
|:---------------------------------|:----|:-------------------|-------:|:----|:--------------------|---------:|:----|:------|----------:|
| Public offering price            |     | $                  | 1.9600 |     | $                   |   1.9599 |     | $     | 5,000,000 |
| Placement agent fees(1)          |     | $                  | 0.1764 |     | $                   | 0.176391 |     | $     |   400,000 |
| Proceeds, before expenses, to us |     | $                  | 1.7836 |     | $                   | 1.783509 |     | $     | 4,600,000 |

| (1) | Includes a cash fee up to 9% of the gross proceeds raised in this offering; provided, however, the cash                 
 fee shall equal 4% of the gross proceeds raised in this offering for securities purchased by a director of the Company. |

<div align='center'>184</div>

Indemnification

We have agreed to indemnify
the placement agent against certain liabilities, including liabilities under the Securities Act and liabilities arising from breaches
of representations and warranties contained in our engagement letter with the placement agent. We have also agreed to contribute to payments
the placement agent may be required to make in respect of such liabilities.

Lock-up Agreements

Each of our executive officers
and directors have agreed with the placement agent to be subject to a lock-up period of 90 days following the date of closing of the
offering pursuant to this prospectus. This means that, during the applicable lock-up period, we and such persons may not offer for sale,
contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate or otherwise dispose of, directly
or indirectly, any of our shares of Common Stock or any securities convertible into, or exercisable or exchangeable for, shares of Common
Stock, subject to customary exceptions. The placement agent may waive the terms of these lock-up agreements in its sole discretion and
without notice.

The ability to pursue a
claim for breach of contract is material to larger purchasers in this offering as a means to enforce the following covenants uniquely
available to them under the securities purchase agreement: (i) a covenant to not enter into variable rate